Kathrin brings over 30 years of health care experience that spans 20 years in the pharmaceutical industry and 15 years in the health care delivery system.

She currently holds the position of Senior Director, Medical Managed Care at Sarepta Therapeutics, a precision genetics medicine company.  In this role, she provides field medical support and communicates scientific information focused in Duchenne Muscular Dystrophy, other dystrophinopathy therapeutic areas and Sarepta pipeline products to payer and managed care organizations. 

Her professional background includes multiple industry medical affairs and health system roles and encompasses expertise in several therapeutic areas including the evolving field of gene therapy.  She has diverse channel experience including health care systems, payers, PBM’s, ACO’s, and IDN’s. 

Dr. Porscha Showers lives in Dallas Fort Worth Area, but grew up in the greater New Orleans area. Her current role is a Patient Access and Quality Principal Medical Scientist at Gilead Sciences where she talks to value based decision makers regarding the value of Gilead’s portfolio which includes, Oncology, HIV, COVID-19, Hepatitis C and B/D. 

Dr. Showers’ prior experiences include the following: Oncology Clinical Trials Pharmacist, Clinical Pharmacist at various hospitals and Staff Pharmacist at Walgreens. She was at Aetna where she served in numerous roles with her most recent being Formulary Manager for 4 Medicaid Plans and 5 Duals Plans while also serving as Assistant Pharmacy Director for Arizona Medicare. Before joining Gilead in 2019, Dr. Showers was an Evidence and Outcomes Liaison at Eli Lilly and Company for the Central Region.

Dr. Showers received her PharmD in 2014 from the Xavier University of Louisiana in New Orleans, Louisiana.  She is an active member of the North Dallas Alumnae Chapter of Delta Sigma Theta Sorority, Inc.,  DFW Graduate Chapter of Kappa Psi Pharmaceutical Fraternity, Inc. and DFW Xavier University of Louisiana Alumni Chapter. She also served on the Board of Directors for the Minority Women’s Pharmacist Association. In her spare time, she loves solo traveling to various countries around the world, exercising and Do It Yourself Projects.

Nazanin Ashourian is the head of U.S. Biosimilars Medical Affairs for Fresenius Kabi. In her role, Nazanin leads all Medical Affairs activities related to the biosimilars portfolio. Prior to joining Fresenius Kabi, Nazanin spent six years at AbbVie (previously Allergan) with roles of increasing responsibility supporting biologics, small molecules, and medical devices. Nazanin holds a Bachelor of Science in molecular and cellular biology from the University of Illinois at Urbana-Champaign and a PhD in biochemistry and molecular genetics from the Johns Hopkins University.

Brandee Pappalardo joined Fresenius Kabi in April 2022 as Senior Vice President, Chief Medical Officer, North America. In her current role, Brandee oversees all Vigilance and Medical Affairs activities related to Pharma Generics/Simplist, Parenteral Nutrition, Biosimilars, Human Factors and Infusion Devices. Prior to joining Fresenius Kabi, she spent 17 years at AbbVie holding affiliate, area and global medical roles of increasing responsibility; her last role as Vice President, Immunology, US Medical Affairs. Brandee holds a bachelor’s degree in Biology from Duke University, an MPH in Epidemiology from UC Berkeley, and a PhD in immunology from NC State University.

Dr. Glenn is a graduate of Texas A&M University and UT Southwestern Medical School. She has work experience in the private sector in solo private practice as well as 16 years in the Community Health Centers in Austin with increasing administrative responsibilities finishing her tenure there as Senior Medical Director. Prior to joining the Department of Aging and Disability Services as the State Office Physician in January of 2012, she was the Medical Director of Central Health, the Travis County Healthcare District. In 2016, Dr. Glenn transitioned into HHSC as the Senior Associate Medical Director for Medicaid-CHIP. She holds board certifications from the American Board of Family Medicine since 1990 and the American Board of Quality Assurance and Utilization Review Physicians since 2007. She is a member of the Texas Medical Association, Travis County Medical Society, American Academy of Family Physicians and Texas Academy of Family Physicians.

Michael Lemnitzer leads the State Government Healthcare business focused on introducing state and local governments with technology across the Philips portfolio such as ventilators, maternal health solutions, remote patient monitoring, eICU/tele-critical care, rural cancer screening, and interoperable HIE Image Network solutions. Mike also serves on the Board of Directors for Texas e-Health Alliance.

Raymon uit de Bulten leads the Pregnancy + Health Insurance and Payers business. Raymon is assisting governments and health plans to improve maternal and infant health while reducing the cost of care. He is focused on introducing solutions that provide a comprehensive pregnancy journey that helps women start with prenatal care on time and increases care compliance.

Steven Nelson leads the Personal Health business focusing on solutions in the oral health and maternal health spaces. Working with Payer partners, the aim is to improve better health outcomes patient and staff experience, and lower cost of care. These solutions support chronic condition management, behavioral changes, and access to care.

Brittany Dawn McAllister serves as a Senior Government Affairs Manager at The National Service Office for Nurse-Family Partnership and Child First. In this role, she oversees public policy and payer strategies to promote the evidence-based services of the NFP and Child First nursing and mental health home visiting models. Brittany holds a BS in Political Communications from The University of Texas at Austin and a MPH in Health Policy from The George Washington University.